64 results
8-K
EX-99.1
5aa1q k5uj07
28 Mar 24
NeuroBo Pharmaceuticals Reports Year End 2023 Financial Results and Provides Corporate Update
8:01am
8-K
o97ppz2f
18 Jan 24
Full Data Readout Expected in the Second Half of 2024
8:30am
8-K
EX-99.1
51yi3le4s 0f65z562
18 Jan 24
Full Data Readout Expected in the Second Half of 2024
8:30am
8-K
EX-99.1
ra777w3a879kt70vj
13 Nov 23
NeuroBo Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:14pm
8-K
EX-99.1
10nzn7trogdxdp
15 Sep 23
NeuroBo Pharmaceuticals Doses First Patient in Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of NASH
8:11am
8-K
EX-10.1
en95r3sx
29 Jun 23
Submission of Matters to a Vote of Security Holders
8:36am
8-K
EX-99.1
trq270ux 63nka99o
30 Mar 23
NeuroBo Pharmaceuticals Reports Full Year 2022 Financial Results
4:47pm
8-K
EX-10.1
239x02hr9c7k4ok
22 Dec 22
Departure of Directors or Certain Officers
5:08pm
8-K
EX-10.2
4yahbl38d5fzpr
22 Dec 22
Departure of Directors or Certain Officers
5:08pm